• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻性活跃印度女性中特定型别人乳头瘤病毒感染的获得、流行和清除:一项基于社区的多中心队列研究。

Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study.

机构信息

Screening Group, Section of Early Detection and Prevention, International Agency for Research on Cancer, Lyon, France.

Infections and Cancer Biology Group, Section of Infections, International Agency for Research on Cancer, Lyon, France.

出版信息

PLoS One. 2020 Dec 29;15(12):e0244242. doi: 10.1371/journal.pone.0244242. eCollection 2020.

DOI:10.1371/journal.pone.0244242
PMID:33373380
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7771682/
Abstract

In context of the ongoing multi-centric HPV vaccine study in India, unvaccinated married women (N = 1484) aged 18-23 years were recruited in 2012-2015 as age-matched controls to the vaccinated women and followed up yearly. We assess type-specific prevalence, natural history and potential determinants of human papillomavirus (HPV) infection in these unvaccinated women. Cervical samples were collected yearly for at least four consecutive years. A Multiplex Type-Specific E7-Based polymerase chain reaction assay was used to detect 21 HPV types. HPV prevalence was 36.4% during 6 years. Most common HPV types were 16 (6.5%) and 31 (6.1%). Highest persistence were observed for HPV 35 (62.5%) and 52 (25%). New HPV acquisition rate was 5.6/1000 person-months of observation (PMO), highest for HPV 16 (1.1/1000 PMO). Type-specific clearance rates ranged between 2.9-5.5/100 PMO. HPV 16 and/or 18 infections were 41% (95% CI 4-63%) lower among women with 2-<3 years between marriage and first cervical sample collection compared to those with <2 years. HPV prevalence and acquisition rates in young Indian women were lower than their Western counterparts. HPV 16 infections being most common shows the importance and potential impact of HPV vaccination in India. Women with 2-3 years exposure had reduced risk possibly due to higher infections clearance.

摘要

在印度正在进行的多中心 HPV 疫苗研究背景下,2012-2015 年招募了未接种 HPV 疫苗的 18-23 岁已婚女性(N=1484)作为接种疫苗女性的年龄匹配对照,并进行了每年一次的随访。我们评估了这些未接种疫苗的女性中 HPV 感染的特定类型流行率、自然史和潜在决定因素。每年收集宫颈样本,至少连续收集四年。使用基于多重 E7 型特异性聚合酶链反应检测 21 种 HPV 型。6 年内 HPV 流行率为 36.4%。最常见的 HPV 类型是 16 型(6.5%)和 31 型(6.1%)。HPV 35 型(62.5%)和 52 型(25%)的持续性最高。新 HPV 感染率为 5.6/1000 人-月观察(PMO),HPV 16 型最高(1.1/1000 PMO)。特定类型的清除率在 2.9-5.5/100 PMO 之间。与首次宫颈样本采集时间<2 年的女性相比,结婚后 2-<3 年的女性 HPV 16 和/或 18 型感染率降低了 41%(95%CI 4-63%)。与西方女性相比,印度年轻女性的 HPV 流行率和感染率较低。最常见的 HPV 16 感染表明 HPV 疫苗接种在印度的重要性和潜在影响。暴露于 HPV 2-3 年的女性感染风险可能降低,这可能是由于 HPV 清除率较高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c14/7771682/8e24c495d01c/pone.0244242.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c14/7771682/2f63587cee1f/pone.0244242.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c14/7771682/8e24c495d01c/pone.0244242.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c14/7771682/2f63587cee1f/pone.0244242.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c14/7771682/8e24c495d01c/pone.0244242.g002.jpg

相似文献

1
Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study.年轻性活跃印度女性中特定型别人乳头瘤病毒感染的获得、流行和清除:一项基于社区的多中心队列研究。
PLoS One. 2020 Dec 29;15(12):e0244242. doi: 10.1371/journal.pone.0244242. eCollection 2020.
2
Human Papillomavirus (HPV) Infection and Risk Behavior in Vaccinated and Non-Vaccinated Paraguayan Young Women.巴拉圭接种和未接种疫苗的年轻女性中的人乳头瘤病毒(HPV)感染与风险行为
Pathogens. 2024 Feb 27;13(3):209. doi: 10.3390/pathogens13030209.
3
Effectiveness of HPV vaccination in reducing infection among young Brazilian women.人乳头瘤病毒疫苗在减少巴西年轻女性感染方面的有效性。
BMC Infect Dis. 2025 Jan 20;25(1):88. doi: 10.1186/s12879-024-10284-5.
4
Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada.在加拿大魁北克省实施基于学校的和补充性疫苗接种后,年轻女性中疫苗型 HPV 感染的流行率较低。
Hum Vaccin Immunother. 2018 Jan 2;14(1):118-123. doi: 10.1080/21645515.2017.1385688. Epub 2017 Dec 13.
5
Comparison of HPV prevalence between HPV-vaccinated and non-vaccinated young adult women (20-26 years).接种HPV疫苗与未接种疫苗的年轻成年女性(20 - 26岁)之间HPV感染率的比较。
Hum Vaccin Immunother. 2015;11(10):2337-44. doi: 10.1080/21645515.2015.1066948.
6
HPV infections and cytologic abnormalities in vaccinated women 21-34 years of age: Results from the baseline phase of the Onclarity trial.21-34 岁接种疫苗女性中的 HPV 感染和细胞学异常:Onclarity 试验基线阶段的结果。
Gynecol Oncol. 2019 May;153(2):259-265. doi: 10.1016/j.ygyno.2019.02.016. Epub 2019 Mar 7.
7
Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy.监测意大利巴西利卡塔地区女性在接种疫苗后时代的疫苗和非疫苗 HPV 型别流行情况。
BMC Infect Dis. 2018 Jan 15;18(1):38. doi: 10.1186/s12879-018-2945-8.
8
Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction.人乳头瘤病毒疫苗接种后 13-26 岁年轻男性任何型和疫苗型肛门生殖器人乳头瘤病毒的流行病学。
J Adolesc Health. 2018 Jul;63(1):43-49. doi: 10.1016/j.jadohealth.2018.01.005.
9
Differences between vaccinated and unvaccinated women explain increase in non-vaccine-type human papillomavirus in unvaccinated women after vaccine introduction.接种疫苗和未接种疫苗的女性之间的差异解释了疫苗接种后未接种疫苗女性中非疫苗型人乳头瘤病毒的增加。
Vaccine. 2017 Dec 19;35(52):7217-7221. doi: 10.1016/j.vaccine.2017.11.005. Epub 2017 Nov 21.
10
Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program.在澳大利亚实施全国性疫苗接种计划后,评估年轻澳大利亚女性中生殖器人乳头瘤病毒的基因型流行情况。
Vaccine. 2015 Jan 1;33(1):201-8. doi: 10.1016/j.vaccine.2014.10.045. Epub 2014 Nov 1.

引用本文的文献

1
Human papillomavirus vaccine use in clinical practice - What dermatologists should know as health care providers.人乳头瘤病毒疫苗在临床实践中的应用——皮肤科医生作为医疗服务提供者应了解的内容。
Indian J Sex Transm Dis AIDS. 2025 Jan-Jun;46(1):7-15. doi: 10.4103/ijstd.ijstd_51_25. Epub 2025 Jun 9.
2
Characteristic of persistent human papillomavirus infection in women worldwide: a meta-analysis.全球女性持续性人乳头瘤病毒感染的特征:一项荟萃分析。
PeerJ. 2023 Nov 14;11:e16247. doi: 10.7717/peerj.16247. eCollection 2023.

本文引用的文献

1
Current status of human papillomavirus vaccination in India's cervical cancer prevention efforts.印度在宫颈癌预防工作中 HPV 疫苗接种的现状。
Lancet Oncol. 2019 Nov;20(11):e637-e644. doi: 10.1016/S1470-2045(19)30531-5.
2
Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years - updated evidence from Indian follow-up cohort study.人乳头瘤病毒疫苗两剂接种建议可延长至18岁——来自印度随访队列研究的最新证据
Papillomavirus Res. 2019 Jun;7:75-81. doi: 10.1016/j.pvr.2019.01.004. Epub 2019 Jan 31.
3
Continuing global improvement in human papillomavirus DNA genotyping services: The 2013 and 2014 HPV LabNet international proficiency studies.
全球 HPV DNA 基因分型服务持续改进:2013 年和 2014 年 HPV 实验室网络国际能力验证研究。
J Clin Virol. 2018 Apr;101:74-85. doi: 10.1016/j.jcv.2018.01.016. Epub 2018 Feb 10.
4
Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial.高危型人乳头瘤病毒初筛阴性女性中特定类型人乳头瘤病毒感染的发生率及持续时间:一项II期HPV-16/18疫苗试验对照组的结果
BMJ Open. 2016 Aug 26;6(8):e011371. doi: 10.1136/bmjopen-2016-011371.
5
Comparison of Two Widely Used Human Papillomavirus Detection and Genotyping Methods, GP5+/6+-Based PCR Followed by Reverse Line Blot Hybridization and Multiplex Type-Specific E7-Based PCR.两种广泛使用的人乳头瘤病毒检测和基因分型方法的比较,即基于GP5+/6+的聚合酶链反应(PCR)后行反向线印迹杂交法,以及基于E7的多重型特异性PCR法
J Clin Microbiol. 2016 Aug;54(8):2031-8. doi: 10.1128/JCM.00618-16. Epub 2016 May 25.
6
Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study.印度女孩接种一剂、两剂和三剂四价人乳头瘤病毒疫苗后的免疫原性和人乳头瘤病毒感染:一项多中心前瞻性队列研究
Lancet Oncol. 2016 Jan;17(1):67-77. doi: 10.1016/S1470-2045(15)00414-3. Epub 2015 Dec 2.
7
Higher prevalence of human papillomavirus infection in adolescent and young adult girls belonging to different Indian tribes with varied socio-sexual lifestyle.在具有不同社会性行为方式的不同印度部落的青春期及年轻成年女性中,人乳头瘤病毒感染率较高。
PLoS One. 2015 May 8;10(5):e0125693. doi: 10.1371/journal.pone.0125693. eCollection 2015.
8
Comparison of hybrid capture II, linear array, and a bead-based multiplex genotyping assay for detection of human papillomavirus in women with negative pap test results and atypical squamous cells of undetermined significance.比较杂交捕获 II、线性阵列和基于珠的多重基因分型检测方法在 Pap 检测结果阴性和非典型鳞状细胞意义不明的女性中检测人乳头瘤病毒的效果。
J Clin Microbiol. 2012 Dec;50(12):4041-6. doi: 10.1128/JCM.02105-12. Epub 2012 Oct 3.
9
Prevalence of high-risk HPV and associated risk factors in cases of cervical carcinoma in Tamil Nadu, India.印度泰米尔纳德邦宫颈癌病例中高危型 HPV 的流行情况及其相关危险因素。
Int J Gynaecol Obstet. 2012 Dec;119(3):253-6. doi: 10.1016/j.ijgo.2012.06.019. Epub 2012 Sep 15.
10
Using HPV prevalence to predict cervical cancer incidence.利用 HPV 流行率预测宫颈癌发病率。
Int J Cancer. 2013 Apr 15;132(8):1895-900. doi: 10.1002/ijc.27835. Epub 2012 Oct 11.